V6 Anti-Human DLL3 (Rovalpituzumab)
Product Specifications
Expression System
CHO
Reactivity
Human
Target
DLL3
Purification
Protein A
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Buffer
ABDB-1002 or PBS, pH 7.4, Contains no stabilizers or preservatives.
Storage Conditions
The product need to be stored at the original stock concentration at 4°C.Avoid freeze / thaw cycle.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives
Sterility
0.2 μM filtered
Isotype
Human IgG1 (E356D/M358L/KDel) -kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740525-100 1x 100 µL
CD63 (MX-49.129.5), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040040-100 1x 100 µL
CD35 / CR1 (E11), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940158-500 1x 500 µL
Cytokeratin 17 (E3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940034-500 1x 500 µL
Cytokeratin 8/18 (C-51), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740266-500 1x 500 µL
Human IgG Immunoglobulin (IG266), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details